Antibody Radionuclide Conjugates Market: How Targeted Radiotherapy...

Ajouter une nouvelle offre d'emploi Health

2026-05-23 08:59:18 -

Antibody Radionuclide Conjugates Market: How Targeted Radiotherapy Is Advancing Precision Oncology

The Antibody Radionuclide Conjugates Market is a high‑technology segment of oncology that combines the targeting‑specificity of monoclonal antibodies with the cell‑killing‑power of attached radionuclides. The Antibody Radionuclide Conjugates Market is growing as developers seek to maximize tumor‑cell‑death while minimizing damage to healthy‑tissue. What are...

0 Commentaires 0 Parts 44 Vue 0 Aperçu